Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.
about
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysisMinimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia.Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia.
P2860
Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapy of core binding factor ...... ward better long-term results.
@en
Therapy of core binding factor ...... ward better long-term results.
@nl
type
label
Therapy of core binding factor ...... ward better long-term results.
@en
Therapy of core binding factor ...... ward better long-term results.
@nl
prefLabel
Therapy of core binding factor ...... ward better long-term results.
@en
Therapy of core binding factor ...... ward better long-term results.
@nl
P2860
P50
P1476
Therapy of core binding factor ...... ward better long-term results.
@en
P2093
Vijaya Raj Bhatt
P2860
P304
P356
10.1016/J.CLML.2012.11.006
P407
P577
2012-12-21T00:00:00Z